Elaine Zaharris
Overview
Explore the profile of Elaine Zaharris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
1520
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marinho L, Everett B, Aday A, Visseren F, MacFadyen J, Zaharris E, et al.
J Am Coll Cardiol
. 2024 Jul;
84(4):408-410.
PMID: 39019534
No abstract available.
2.
Connors J, Brooks M, Sciurba F, Krishnan J, Bledsoe J, Castro L, et al.
NEJM Evid
. 2024 Feb;
1(12):EVIDctcs2200149.
PMID: 38319835
Outpatient Trials in the Covid-19 Era and BeyondA group of investigators had a meeting at the National Heart, Lung, and Blood Institute in May 2020 to discuss ways to decrease...
3.
Bledsoe J, Woller S, Brooks M, Sciurba F, Krishnan J, Martin D, et al.
BMC Infect Dis
. 2023 May;
23(1):325.
PMID: 37189091
Background: Assessment for risks associated with acute stable COVID-19 is important to optimize clinical trial enrollment and target patients for scarce therapeutics. To assess whether healthcare system engagement location is...
4.
Connors J, Brooks M, Sciurba F, Krishnan J, Bledsoe J, Kindzelski A, et al.
JAMA
. 2021 Oct;
326(17):1703-1712.
PMID: 34633405
Importance: Acutely ill inpatients with COVID-19 typically receive antithrombotic therapy, although the risks and benefits of this intervention among outpatients with COVID-19 have not been established. Objective: To assess whether...
5.
Ridker P, Everett B, Pradhan A, MacFadyen J, Solomon D, Zaharris E, et al.
N Engl J Med
. 2018 Nov;
380(8):752-762.
PMID: 30415610
Background: Inflammation is causally related to atherothrombosis. Treatment with canakinumab, a monoclonal antibody that inhibits inflammation by neutralizing interleukin-1β, resulted in a lower rate of cardiovascular events than placebo in...
6.
Christen W, Cook N, Van Denburgh M, Zaharris E, Albert C, Manson J
J Am Heart Assoc
. 2018 May;
7(11).
PMID: 29776960
Background: The aim of this study was to determine whether reducing plasma homocysteine concentrations with long-term, combined treatment with folic acid, vitamin B, and vitamin B alters plasma biomarkers of...
7.
Everett B, Pradhan A, Solomon D, Paynter N, MacFadyen J, Zaharris E, et al.
Am Heart J
. 2013 Jul;
166(2):199-207.e15.
PMID: 23895801
Background: Inflammation plays a fundamental role in atherothrombosis. Yet, whether direct inhibition of inflammation will reduce the occurrence of adverse cardiovascular outcomes is not known. Design: The Cardiovascular Inflammation Reduction...
8.
Manson J, Bassuk S, Lee I, Cook N, Albert M, Gordon D, et al.
Contemp Clin Trials
. 2011 Oct;
33(1):159-71.
PMID: 21986389
Data from laboratory studies, observational research, and/or secondary prevention trials suggest that vitamin D and marine omega-3 fatty acids may reduce risk for cancer or cardiovascular disease (CVD), but primary...
9.
Lin J, Cook N, Albert C, Zaharris E, Gaziano J, Van Denburgh M, et al.
J Natl Cancer Inst
. 2009 Jan;
101(1):14-23.
PMID: 19116389
Background: Observational studies suggested that a diet high in fruits and vegetables, both of which are rich with antioxidants, may prevent cancer development. However, findings from randomized trials of the...
10.
Albert C, Cook N, Gaziano J, Zaharris E, MacFadyen J, Danielson E, et al.
JAMA
. 2008 May;
299(17):2027-36.
PMID: 18460663
Context: Recent randomized trials among patients with preexisting cardiovascular disease (CVD) have failed to support benefits of B-vitamin supplementation on cardiovascular risk. Observational data suggest benefits may be greater among...